| Hang Seng Index | 26.020 HKD | -0.340 | -1.290% | 624.98M | 16.36B | 25.859 (+0.625%) HKD as at 2025/08/22 | | |
| Hang Seng China Enterprises | 93.500 HKD | -1.120 | -1.184% | 114.75M | 10.81B | 92.905 (+0.641%) HKD as at 2025/08/22 | | |
| Hang Seng TECH Index | 5.675 HKD | -0.035 | -0.613% | 1.75B | 9.96B | 5.547 (+2.317%) HKD as at 2025/08/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.960 HKD | -0.090 | -1.488% | 164.37M | 992.10M | 5.710 (+4.378%) HKD as at 2025/08/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.416 HKD | +0.024 | +1.724% | 402.84M | 563.91M | 1.487 (-4.781%) HKD as at 2025/08/22 | | |
| Hang Seng TECH Index | 12.180 HKD | -0.090 | -0.733% | 42.43M | 520.40M | 11.901 (+2.343%) HKD as at 2025/08/22 | | |
| Hang Seng TECH Index | 5.760 HKD | -0.040 | -0.690% | 56.86M | 329.92M | 5.632 (+2.269%) HKD as at 2025/08/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.928 HKD | +0.048 | +2.553% | 147.62M | 281.26M | 1.963 (-1.788%) HKD as at 2025/08/22 | | |
| CSI 300 | 50.260 HKD | -0.160 | -0.317% | 5.16M | 260.12M | 49.260 (+2.030%) HKD as at 2025/08/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.915 HKD | -0.150 | -2.473% | 35.56M | 213.37M | 5.843 (+1.237%) HKD as at 2025/08/22 | | |
| FTSE China A50 | 15.950 HKD | -0.120 | -0.747% | 10.57M | 169.18M | 15.693 (+1.637%) HKD as at 2025/08/22 | | |
| Hang Seng China Enterprises | 10.830 HKD | -0.010 | -0.092% | 12.04M | 130.54M | 10.749 (+0.756%) HKD as at 2025/08/22 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 17.280 HKD | -0.300 | -1.706% | 7.37M | 127.76M | 17.587 (-1.743%) HKD as at 2025/08/22 | | |
| London Gold Fixing Price | 2,425.000 HKD | +6.000 | +0.248% | 31.98K | 77.59M | N/A | | |
| FTSE China A50 | 14.850 HKD | -0.120 | -0.802% | 5.10M | 76.00M | 14.592 (+1.765%) HKD as at 2025/08/22 | | |
| MSCI China A 50 Connect Index (net total return index) | 26.900 HKD | -0.180 | -0.665% | 1.19M | 32.23M | 26.283 (+2.349%) HKD as at 2025/08/22 | | |
| MSCI Asia APEX 50 | 65.380 HKD | -0.800 | -1.209% | 415.76K | 27.30M | 65.177 (+0.311%) HKD as at 2025/08/22 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.580 HKD | -0.410 | -3.731% | 2.47M | 25.97M | 10.327 (+2.448%) HKD as at 2025/08/22 | | |
| CSI 300 | 32.880 HKD | -0.260 | -0.785% | 768.40K | 25.42M | 32.318 (+1.739%) HKD as at 2025/08/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 6.015 HKD | -0.150 | -2.433% | 3.28M | 20.03M | 5.747 (+4.656%) HKD as at 2025/08/22 | | |
| SSE Science and Technology Innovation Board 50 Index | 11.740 HKD | -0.180 | -1.510% | 1.47M | 17.32M | 11.481 (+2.257%) HKD as at 2025/08/22 | | |
| CSI 300 | 46.120 CNY | -0.160 | -0.346% | 348.75K | 16.10M | 45.296 (+1.820%) CNY as at 2025/08/22 | | |
| Hang Seng High Dividend Yield | 30.480 HKD | -0.060 | -0.196% | 514.01K | 15.70M | 30.397 (+0.274%) HKD as at 2025/08/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.792 HKD | +0.020 | +0.530% | 4.01M | 15.21M | 3.757 (+0.926%) HKD as at 2025/08/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.608 HKD | -0.060 | -1.285% | 3.06M | 14.21M | 4.476 (+2.944%) HKD as at 2025/08/22 | | |
| FTSE US Treasury 20+ Years Index | 67.380 HKD | -0.400 | -0.590% | 195.50K | 13.19M | 67.962 (-0.857%) HKD as at 2025/08/22 | | |
| SSE Science and Technology Innovation Board 50 Index | 8.495 HKD | -0.185 | -2.131% | 1.54M | 13.09M | 8.341 (+1.850%) HKD as at 2025/08/22 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.560 HKD | -0.140 | -1.022% | 930.40K | 12.56M | 13.914 (-2.546%) HKD as at 2025/08/22 | | |
| CME Ether Futures | 20.740 HKD | -0.800 | -3.714% | 478.51K | 9.94M | 22.704 (-8.651%) HKD as at 2025/08/22 | | |
| MSCI China | 27.160 HKD | -0.280 | -1.020% | 345.34K | 9.43M | 26.838 (+1.201%) HKD as at 2025/08/22 | | |